ADAM12 and small cell lung carcinoma: This indicates that ADAM-12 levels in serum and urine are correlated with SCLC progression and that ADAM-12 can be considered to be a diagnostic marker for SCLC disease since the expression of ADAM-12 increased with the development and progression of disease.